Michael Salzmann honored as Corporate Professional of the Year by The M&A Advisor

Neurimmune's COO Michael Salzmann received the 2nd Annual EMEA Corporate Growth Award in the category Corporate Development Professional in recognition of his outstanding achievements as Neurimmune’s executive and his additional role as CEO of AL-S Pharma AG. AL-S Pharma AG has been created by Neurimmune and TVM Capital Life Science to develop innovative therapies for patients with ALS. The M&A Advisor announced the 2018 winners in partnership with S&P Global Market Intelligence to honor top transactions, firms, teams and professionals.